A Fairer Playing Field
March 25, 2019
Enforcing antitrust and merger rules. A recently published report shows how the European Commission has protected patients against anticompetitive practices over the last decade.
0 min read
False
Advertisement
Mar
Advanced Therapies: The Price is Right?
March 25, 2019
Health technology assessments find that many cell and gene therapies are more cost effective than existing treatments and managing symptoms with palliative care. But are healthcare systems and manufacturers ready to embrace evidence-based pricing to lessen the impact of upfront costs?
0 min read
Building a Business: Lessons Learned with Angela Osborne
March 25, 2019
Not allowing herself to be defined by stereotypes, Angela Osborne has created her own space in the industry and is helping the cell and gene therapy industry to bloom. Here, she shares the pivotal moments leading to the creation of the consultancy, eXmoor Pharma.
0 min read
Batch Relief
March 25, 2019
The EU will allow companies to conduct quality control testing in the UK after a “no deal” Brexit – at least under certain conditions and for a limited time
0 min read
It’s Complicated
March 22, 2019
The potential market for complex generics is substantial, but navigating the FDA’s guidance for proving “sameness” is a real minefield...
0 min read
A Step Change in Pharmaceutical Glass Packaging Innovation
March 22, 2019
Corning’s analysis into the root cause of glass delamination-related recalls identified boron as the culprit, explaining why process control of borosilicate vials only reduce the risk. As a result, Corning glass scientists developed Valor® Glass, a revolutionary, new aluminosilicate glass composition, developed specifically for pharmaceutical use to eliminate delamination.
0 min read
World TB Day: Understanding the Roadblocks to Progress
March 22, 2019
Tuberculosis, though curable and in part preventable, remains one of the top ten causes of death and poverty worldwide. Why?
0 min read
NextGen Now: Delivering Tomorrow's Facilities Today
March 22, 2019
If cell and gene therapy products are to successfully reach patients and deliver transformative cures, then the industry will need more facilities capable of manufacturing them.
0 min read
The Upstream/Downstream Process Balancing Act
March 22, 2019
Early collaboration and open communication between upstream and downstream are crucial to ensure a consistent end-to-end bioprocess.
0 min read
Perusing the Pipeline
March 19, 2019
With cell and gene therapies being all the rage, we take a peek at some of the advanced therapies coming down the pipe – from preclinical studies through to phase III trials.
0 min read
Browse by Topics
Interviews
Cell & Gene
Bioprocessing
Drug Delivery
Drug Discovery
Development & Clinical
Formulation
Facilities & Equipment
Outsourcing
Packaging
Regulation & Standards
Small Molecules
Supply Chain
Industry News
Research News
Sitting Down With
Innovation Awards
Business & Trends
Technology & Manufacturing
Biopharma
Future of Pharma
Latest
Blogs